ARZNEIMITTELABGABEVORRICHTUNG

European patent · EP4319844 · In force

Register entry

Publication number
EP4319844
Application number
EP22721358
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 7, 2022
Published
Feb 14, 2024
Granted
Dec 24, 2025
Protection ends at the latest
Apr 6, 2042
Next annual fee due
Apr 30, 2027
IPC classes
A61M 5/24 (2006.01)
A61M 5/315 (2006.01)
Priority
EP 21167293 07.04.2021
EP 21181883 25.06.2021
EP 21181887 25.06.2021
EP 21184545 08.07.2021
US 202117472546 10.09.2021
US 202117472550 10.09.2021
US 202117472554 10.09.2021
US 202117472561 10.09.2021
EP 21202384 13.10.2021
PCT application
PCT/EP2022/059334 07.04.2022
PCT publication
WO2022/214625 13.10.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 4, 2026

    Change

    Published in Swissreg on 04.11.2026

  2. May 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.04.2026 → 30.04.2027

    Published in Swissreg on 01.05.2026

  3. Jan 6, 2026

    Agent entered

    Representative
    IPS Irsch AG, Langfeldstrasse 88, 8500 Frauenfeld

    Published in Swissreg on 06.01.2026

  4. Dec 24, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 24.12.2025

Parties

Holder

medmix Switzerland AG

Rütistrasse 7, 9469 Haag (Rheintal)

Agent

IPS Irsch AG

Langfeldstrasse 88, 8500 Frauenfeld

Inventor

MÜLLER, Heiko

70563 Stuttgart, DE

REUBZAET, Wouter

6444 DE Brunssum, NL

HILD, André

52064 Aachen, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.